Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-19-004571

Director bought 3,100 shares at an average $0.69 ($2,131)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
HILZINGER KURT J Director 2019-01-16 Purchase +800 $0.68 $544 112,147 D: show line 1 in the form
HILZINGER KURT J Director 2019-01-17 Purchase +2,300 $0.69 $1,587 114,447 D: show line 2 in the form
Open-market purchases · 3,100 sh · avg $0.69 · $2,131
Loading xslF345X03/doc4.xml…